Company: PaceMate
Co-Founders: Tripp Higgins (chairman of the board), Jason Hale, Noemi Ray, Gabe Rosu
Website: https://pacemate.com/
About PaceMate
PaceMate is the always-on cardiac device management platform with optional remote monitoring services that leading clinicians trust to automate workflows, prioritize critical patients and deliver better and faster care. With over 2 million patients under management and trusted by health systems including Duke Health, Advocate Health and many others, PaceMate is helping healthcare providers modernize and scale their cardiac care delivery.
The company was founded in 2015 by industry veterans who saw firsthand the challenges clinicians face in managing the overwhelming volume and complexity of cardiac data across multiple different providers and systems. For example, there are over ten different manufactures for implantable and wearable heart monitoring devices – each with their own online portal to track patient data. This means when a physician wanted to check for any patient alerts, they would need to manually log into all the different systems and check for updates – which is a time consuming process. Additionally, the data from the cardiac monitoring systems needed to be manually uploaded into a patients chart. This fragmented and slow workflow was ultimately reducing efficiency at clinics and preventing them from providing the best patient care.
In response, founders of PaceMate built what is now the most comprehensive end-to-end remote cardiac monitoring platform in the industry. The cloud-based system enables care teams to manage cardiac device patients through a single, end-to-end platform that integrates with every major EHR and every major device vendor. Instead of needing to track data across multiple different websites, physicians can see all patient data, regardless of the device manufacturer, on a single interface while automatically logging data into patient charts. This streamlined workflow led to healthcare providers reporting over 2,000 hours saved per year.
With always up-to-date, comprehensive data, PaceMate delivers actionable insights for providers to optimize practice performance and drive better patient outcomes. For example, physicians can set alert thresholds based on irregular heart activity – allowing them to attend to their patients with the most pressing heart concerns, quickly.
Since its founding, PaceMate’s innovation roadmap has been shaped by the clinicians and care teams who directly rely on it. As a result, the platform is uniquely designed to meet the real-world workflows and clinical demands of cardiac care.
As part of its innovation roadmap, PaceMate acquired the Medtronic PaceArt Optima system, which was an on-premise system. Now, with more health systems than ever looking to migrate legacy monitoring systems to the cloud, PaceMate is focused on helping these providers make the switch with as little disruption to their daily workflows as possible. As the only cardiac remote monitoring platform with access to historical PaceArt data, PaceMate ensures providers have full access to the historical data from their on-premise system, now available in the cloud. Additionally, PaceMate is committed to delivering feature parity between the PaceArt and PaceMate systems. The company is working to launch the same capabilities that providers loved with PaceArt, now on a more robust platform, to ensure minimal disruption while providing the best possible patient care.
